Results 71 to 80 of about 466,154 (153)

Novel Rare Variants in Congenital Cardiac Arrhythmia Genes are Frequent in Drug-induced Torsades de Pointes

The Pharmacogenomics Journal, 2012
Marked prolongation of the QT interval and polymorphic ventricular tachycardia following medication (drug-induced long QT syndrome, diLQTS) is a severe adverse drug reaction (ADR) that phenocopies congenital long QT syndrome (cLQTS) and is one of the ...
A. Ramirez, C. Shaffer, J. Delaney, D. Sexton, S. Levy, M. Rieder, D. Nickerson, A. George, D. Roden   +8 more
semanticscholar   +1 more source

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review

Heart Rhythm, 2020
Lior Jankelson, Giorgio Karam, M. Becker, L. Chinitz, Meng-Chiao Tsai   +4 more
semanticscholar   +1 more source

Dilated Cardiomyopathy Compatible With Sarcoidosis Presenting with Syncope Due to Torsades de Pointes: a Case Report

Journal of Cardiac Arrhythmias, 2020
Sarcoidosis is a multisystemic noncaseating granulomatous disease of unknown etiology. Cardiac sarcoidosis clinical presentation is diverse, and syncope is one of the possible primary events.
Carollina Fernandes Tinoco, Nathalia Rodrigues Perrenoud Branca, Gabriela Domingues Carvalho, Lívia Silva de Paula Faria, Erivelton Alessandro do Nascimento   +4 more
doaj   +4 more sources

Acquired long QT syndrome and Torsades de Poin

The Egyptian Heart Journal, 2016
Acetylcholinesterase inhibitors are group of drugs commonly used in Alzheimer disease and have beneficial effects on treatment. Although they have many known side effects, cardiovascular side effects are rarely seen.
Ahmet Seyfeddin Gurbuz, Semi Ozturk, Emrah Acar, Süleyman Çagan Efe, Taylan Akgun, Alev Kilicgedik, Ahmet Guler, Cevat Kirma   +7 more
doaj   +1 more source

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine

Research in Social and Administrative Pharmacy, 2020
A. Sarayani, B. Cicali, Carl H Henriksen, Joshua D. Brown   +3 more
semanticscholar   +1 more source

Flecainide associated torsade de pointes: A potential case of reverse use dependence

Journal of Research in Medical Sciences, 2013
Flecainide has been known to cause torsades de pointes (TdP) in patients with structural heart disease and its mechanism has been attributed to use-dependency.
Kevin Hayes, Abhishek Deshmukh, Sadip Pant, Benjamin Culp, James Marsh, Hakan Paydak   +5 more
doaj  

Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019

Heart Rhythm, 2020
Y. Szekely, Yael Lichter, B. Shrkihe, Hila Bruck, H. Oster, S. Viskin   +5 more
semanticscholar   +1 more source

Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study

Drug, Healthcare and Patient Safety, 2011
Matthew J Hafermann1, Rocsanna Namdar2, Gretchen E Seibold2,3, Robert Lee Page 2nd2,31University of Washington Medical Center, Department of Pharmacy, Seattle, WA; 2University of Colorado Anschutz Medical Campus, School of Pharmacy, Aurora, CO ...
Hafermann MJ, Namdar R, Seibold GE, Page RL 2nd   +3 more
doaj  

Drug-induced QT interval prolongation and torsades de pointes

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2016
J. Tisdale
semanticscholar   +1 more source

Improved Prediction of Drug‐Induced Torsades de Pointes Through Simulations of Dynamics and Machine Learning Algorithms

Clinical pharmacology and therapy, 2016
M. Lancaster, E. Sobie
semanticscholar   +1 more source